Naya Biosciences Inc.
13F holders, Q1 2024 (March 31)11holders
$1.12avg. 13F price*
At the end of Q1 2024, 11 institutions reported holding Naya Biosciences Inc. in their 13F filings. The largest holders were Vanguard Group Inc. ($61K), Geode Capital Management, LLC ($27K) and Sabby Management, LLC ($21K).
- Company
- Naya Biosciences Inc.
- Filed as
- INVO BIOSCIENCE INC (Q1 2024)
- CUSIP
- 44984F401
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $32 |
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | No change | 54,058 | $61K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.4% | 24,852 | $27K |
| Sabby Management, LLC | 0.15% | No change | 18,624 | $21K |
| UBS Group AG | 0.00% | Add +13.2% | 8,102 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.0% | 6,922 | $8K |
| Royal Bank of Canada | 0.00% | No change | 538 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 559 | $632 |
| Aspire Private Capital, LLC | 0.00% | No change | 115 | $130 |
| Morgan Stanley | 0.00% | No change | 37 | $42 |
| Wells Fargo & Company | 0.00% | Add +5.9% | 18 | $20 |
| Gleason Group, Inc. | 0.00% | No change | 3 | $3 |
"% of holder's portfolio" is NAYA BIOSCIENCES INC's weight in each manager's 13F, not the share of Naya Biosciences Inc. the manager owns.